|Combined Injectable Contraceptive|
|Birth control type||
|Failure rates (first year)|
|Advantages and disadvantages|
Especially good if poor pill compliance.|
Combined injectable contraceptive (CIC) monthly injection of a progestin and a synthetic estrogen taken to suppress fertility. Brand names include Cyclofem, Novafem, Mesigyna, Lunelle and Cyclo-Provera.
DMPA is a different injectable contraceptive, containing just a progestin, given every three months.
|The examples and perspective in this article may not represent a worldwide view of the subject. (March 2013)|
- October 5, 2000, Pharmacia received FDA approval for Lunelle Monthly Contraceptive Injection.
- April 2003, Pharmacia acquired by Pfizer (makers of Depo-Provera (DMPA)).
- October 2003, Lunelle was discontinued in the U.S.
Use and packaging
Administered by intramuscular injection into the deltoid, gluteus maximus, or anterior thigh. Ideally administered every 28 to 30 days, though demonstrated to be effective up to 33 days.
The most prominent side effects are menstrual irregularities during the first 3 to 6 months of use.
Lua error in package.lua at line 80: module 'Module:Buffer' not found.